1/19/2023China Issues the Measures for Linking the Drug Administrative Law Enfo...

1/19/2023NHC Issues Notice to Step Up Clinical Use Regulation of Pediatric Drug...

1/19/2023After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...

1/19/2023AbbVie, Novartis and More Win National Coverage in China Even as Pfize...

1/19/2023Chinese Market Biosimilar Update (JDSupra)

1/18/2023Lilly and AffaMed Enter Pact for Commercialization of Migraine Drug Ga...

1/18/2023China Issues Notice to Encourage Foreign Capital to Set up R&D Centers...

1/18/2023NHSA and MOHRSS Jointly Issues the 2022 National Drug Reimbursement Li...

1/18/2023Moderna in Active Discussions with China to Supply COVID Vaccines

1/17/2023Sinovent Pharma Sign Two Out-licensing Deals with METiS and AmMax Bio

1/16/2023NHSA Holds 2023 National Healthcare Security Conference, Laying Out Po...

1/16/2023The China Imperative for Multinational Companies

1/13/2023HSMAP: Chinese MedPharm Industry Operations Report 2022

1/13/2023PhIRDA: Early Stage Financing and Recent Startups Dominate Chinese Pha...

1/13/2023AstraZeneca, Genertec Meheco Sign Deal for COVID Therapy Evusheld in C...

1/13/2023MNCs to Play Key Role in Improving Cardiovascular Disease Management A...

1/12/2023Information Collection on the 8th VBP Officially Initiated

1/12/2023Astellas Sues Qilu Pharma in the U.S. to Block Its Generic Bladder Dru...

1/12/2023MNC Incubators in China (PharmaDJ)

1/11/2023Merck to Take Legal Action against Unauthorized Distributors of Its C...

1/11/2023Merck's Covid Drug Molnupiravir Could Be Available in China Soon: Sino...

1/11/2023Hepalink Invests $60M with TPG Biotechnology fund

1/10/2023AmMax and Evopoint Enter into an Exclusive Option Agreement to License...

1/9/2023NMPA Announces Package Insert Revision of Ibandronate Sodium Inj and T...

1/9/2023Simnova and Orna Thera Collaborate to Advance Orna's Next Gen Circular...

1/9/2023Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...

1/6/2023Top The Chinese Pharma In-licensing Deals in 2022 (PharmCube)

1/6/2023Top Ten Chinese Biopharma Out-licensing Deals in 2022 (PharmCube)

1/6/2023CDE Solicits Comments on the Technical Guidelines for R&D of TCM Impro...

1/6/2023CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M11

Page:75/377 Total number of articles:11301: [First][<<] [73] [74] [75] [76] [77] [>>] [End]